Your browser doesn't support javascript.
loading
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate.
Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio.
Afiliación
  • Tanaka Y; University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Yamanaka H; Saitama Medical University, Saitama, Japan.
  • Nanki T; Rheumatology, Sanno Medical Center, Tokyo, Japan.
  • Umehara H; Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
  • Yasuda N; Division of Rheumatology and Immunology, Nagahama City Hospital, Shiga, Japan.
  • Tago F; KAN Research Institute, Inc., Kobe, Japan.
  • Kitahara Y; Eisai Co. Ltd, Tokyo, Japan.
  • Kawakubo M; Eisai Co. Ltd, Tokyo, Japan.
  • Torii K; Eisai Co. Ltd, Tokyo, Japan.
  • Hojo S; Eisai Inc., Nutley, NJ, USA.
  • Kawano T; Eisai Co. Ltd, Tokyo, Japan.
  • Imai T; Eisai Co. Ltd, Tokyo, Japan.
Mod Rheumatol ; 34(1): 37-44, 2023 Dec 22.
Article en En | MEDLINE | ID: mdl-36680426

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Tipo de estudio: Clinical_trials Idioma: En Revista: Mod Rheumatol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Tipo de estudio: Clinical_trials Idioma: En Revista: Mod Rheumatol Año: 2023 Tipo del documento: Article